Key players in Alexipharmic Drugs
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 |  AstraZeneca |
astrazeneca.com (opens in a new tab) | 957 reports |
| 2 |  Bristol-Myers Squibb |
bms.com (opens in a new tab) | 627 reports |
| 3 |  Teva Pharmaceutical |
tevapharm.com (opens in a new tab) | 462 reports |
| 4 |  Sun Pharmaceutical Industries Ltd. |
sunpharma.com (opens in a new tab) | 264 reports |
| 5 | Mylan N.V. | — | 132 reports |
| 6 |  Novartis AG |
novartis.com (opens in a new tab) | 1,551 reports |
| 7 |  Sanofi |
sanofi.com (opens in a new tab) | 1,386 reports |
Also active in Alexipharmic Drugs
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 Amgen Inc. |
|
 Hikma Pharmaceuticals PLC |
|
| Specgx LLC | |
| Hospira Inc | |
 Amneal Pharmaceuticals, Inc |
|
| Rhodes Pharmaceuticals | |
| Aurolife Pharma LLC | |
 Fresenius SE & CO |
|
| Ascent Pharmaceuticals Inc | |
| Alvogen | |
| Knoa Pharma | |
| Epic Systems Corporation |
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Alexipharmic Drugs
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Alexipharmic Drugs reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Alexipharmic Drugs report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.